Loading stock data…
QDEL
$18.23+4.44 (+32.20%)
Market ClosedLast close Jun 29
QuidelOrtho Corporation provides diagnostic testing solutions.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
QuidelOrtho Corporation in the Healthcare sector is trading at $18.23 with a market capitalization of $982M. Wall Street consensus targets $18.62 (4 analysts), implying a +2.2% move over the next 12 months. The stock is currently 49% below its 52-week high of $35.58, remaining 17.8% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $619.80M↓ | $723.60M↑ | $699.90M↑ | $613.90M↓ | $692.80M |
| Gross Profit | $263.80M↓ | $320.40M↓ | $335.60M↑ | $274.90M↓ | $343.30M |
| Operating Income | -$27.40M↑ | -$37.30M↓ | $45.20M↑ | -$1.80M↓ | $48.70M |
| Net Income | -$91.80M↑ | -$130.70M↑ | -$733.00M↓ | -$255.40M↓ | -$12.70M |
Peer Comparison
JNJUNHPFE
Fundamentals
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$981.61M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-65.40%
Volume
Today's trading volume
6.54M
Recent News
QuidelOrtho (QDEL) Stock Trades Up, Here Is Why
Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) jumped 34.7% in the afternoon session after reports revealed that the company is considering the sale of its point-of-care testing business for about $1.5 billion.
Sector Update: Healthcare Stocks Higher Late Afternoon
Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index up 0.1% and the
QDEL Stock Eyes Best Day In Over A Year — Point-Of-Care Sale Talks Ignite Rally
QuidelOrtho is in talks to sell its point-of-care testing unit behind the rapid antigen tests for Covid and flu, Financial Times reported over the weekend.
3 Small-Cap Stocks with Open Questions
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
1 Unprofitable Stock to Consider Right Now and 2 We Ignore
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.